We are live on ! Find out more
IART icon

Integra LifeSciences

261 hedge funds and large institutions have $5.26B invested in Integra LifeSciences in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 101 increasing their positions, 75 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 101 | Existing positions reduced: 75

2.46% more ownership

Funds ownership: 88.46%90.91% (+2.5%)

3% more capital invested

Capital invested by funds: $5.09B → $5.26B (+$167M)

2% more call options, than puts

Call options by funds: $17.2M | Put options by funds: $16.8M

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 30

1% less funds holding

Funds holding: 264261 (-3)

Holders
261
Holders Change
-3
Holders Change %
-1.14%
% of All Funds
4.57%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
30
Increased
101
Reduced
75
Closed
30
Calls
$17.2M
Puts
$16.8M
Net Calls
+$377K
Net Calls Change
-$1.33M
Name Holding Trade Value Shares
Change
Change in
Stake
TPSF
76
Texas Permanent School Fund
Texas
$3.69M +$62.2K +880 +2%
AB
77
Amalgamated Bank
New York
$3.63M -$307K -4,348 -8%
Russell Investments Group
78
Russell Investments Group
United Kingdom
$3.51M -$30K -424 -0.8%
FNBOO
79
First National Bank of Omaha
Nebraska
$3.45M -$260K -3,679 -7%
ETC
80
Exchange Traded Concepts
Oklahoma
$3.24M -$567K -8,020 -14%
D.E. Shaw & Co
81
D.E. Shaw & Co
New York
$3.15M -$3.12M -44,190 -49%
Barclays
82
Barclays
United Kingdom
$3.12M -$687K -9,729 -18%
OCM
83
Olstein Capital Management
New York
$2.81M -$353K -5,000 -11%
Thrivent Financial for Lutherans
84
Thrivent Financial for Lutherans
Minnesota
$2.62M +$3.25K +46 +0.1%
Prudential Financial
85
Prudential Financial
New Jersey
$2.61M +$281K +3,975 +12%
State of New Jersey Common Pension Fund D
86
State of New Jersey Common Pension Fund D
New Jersey
$2.57M +$54.5K +772 +2%
SFI
87
Susquehanna Fundamental Investments
Pennsylvania
$2.53M -$332K -4,700 -11%
HW
88
Hancock Whitney
Mississippi
$2.42M +$37.7K +534 +2%
Comerica Bank
89
Comerica Bank
Texas
$2.41M -$411K -5,821 -15%
MIM
90
MetLife Investment Management
New Jersey
$2.39M -$38.4K -543 -2%
VRS
91
Virginia Retirement Systems
Virginia
$2.38M +$1.3M +18,400 +112%
Canada Life
92
Canada Life
Manitoba, Canada
$2.37M +$481K +6,804 +25%
UBS Group
93
UBS Group
Switzerland
$2.29M -$538K -7,612 -19%
PI
94
PineBridge Investments
New York
$2.29M +$2.36M +33,427 New
DA
95
Duality Advisers
Florida
$2.1M +$1.24M +17,582 +134%
T. Rowe Price Associates
96
T. Rowe Price Associates
Maryland
$2.07M +$110K +1,551 +5%
EP
97
Edgestream Partners
New Jersey
$1.98M -$2.36M -33,420 -54%
TC
98
TwinBeech Capital
New York
$1.9M +$168K +2,384 +9%
FDCDDQ
99
Federation des caisses Desjardins du Quebec
Quebec, Canada
$1.9M +$1.96M +27,740 New
PNC Financial Services Group
100
PNC Financial Services Group
Pennsylvania
$1.82M +$41.8K +591 +2%

IART Hedge Fund Activity: Q3 2021 in Review

261 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2021, worth a combined $5.26B — up 3.3% from $5.09B a quarter earlier.

Fund positioning in IART was balanced in Q3 2021: 30 funds opened new positions, 30 closed out, 101 added to existing stakes and 75 trimmed.

The largest buyer was AllianceBernstein, adding an estimated $140M. The largest seller was Champlain Investment Partners, cutting an estimated $55.3M.

  • 261 institutional investors held Integra LifeSciences (IART) as of Q3 2021, down from 264 in Q2 2021.
  • Funds reported $5.26B of Integra LifeSciences stock for Q3 2021, up 3.3% quarter-over-quarter.
  • 30 funds opened new Integra LifeSciences positions in Q3 2021 and 30 closed out, a net change of 0 holders.
  • The largest Integra LifeSciences buyer in Q3 2021 was AllianceBernstein, an estimated $140M added.
  • The largest Integra LifeSciences seller in Q3 2021 was Champlain Investment Partners, an estimated $55.3M sold.

Based on aggregated 13F filings for Q3 2021.